The Carlat Psychiatry Podcast
The Choice: Meds for Tardive Dyskinesia
January 20, 2020
With two medications approved for tardive dyskinesia, how do you choose between them? And how does anyone afford their $80-140,000 a year price tag? We'll walk you through the steps, and show you how to get these VMAT2 inhibitors approved by insurance. Date
Published: 1/20/2020
Duration: 23 minutes, 51 seconds
Article Referenced: "How to Treat Tardive Dyskinesia," The Carlat Psychiatry Report, January 2020
Take the Podcast Survey to help us launch a CME option in 2020.
United States
Clear, engaging, and practical updates on clinical psychiatry. Hosted by Chris Aiken, MD, and Kellie Newsome, PMHNP.
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast